Today, wanted to write a little about Main Street Capital, Ticker symbol is MAIN. Beloved by many dividend investors and other fixed income investors.
They coin themselves as the “Main Street” and not Wall Street, when it comes to providing liquidity, investment and debt financing.
Why do dividend investors love this stock? Is it because they pay a MONTHLY dividend?
Let’s dive in and see if MAIN should be a MAIN part of your dividend stock portfolio! Continue reading
7 months go, 5 remain in 2023. We are cruising through 2023 and are marching towards financial freedom! At the end of each month, we review our dividend income to monitor our growth and progress. In this article, I share my July dividend income summary and some key observations about our strong growth!
This is what dividend investing is all about! Investing in dividend stocks allows YOU to earn dividend income, the best passive income stream! Bias, you better believe it.
Time to dive into Lanny’s July 2023 dividend income results! Were records set? Almost to financial freedom? One day and one month at a time!
Another month is upon us as we cruise through 2023. Each month, we look ahead to the upcoming dividend increases. In this article, we will feature 5 expected dividend increases in August. The article will feature 4 Dividend Kings and 1 Dividend Aristocrat!
Continue reading
Here are the TWO dividend stocks on my radar this month! Always buying stocks, no matter what is happening in the stock market. The stock market can go up and can go down, but the Dividend Diplomats are buying dividend stocks and adding to the passive income stream.
Let’s review two dividend stocks hot on my radar right now!
Fundrise is an online crowd funding platform that allows investors to invest into real estate. The platform provides another avenue for passive income that can be helpful on the journey to financial freedom! That is the exact reason we have been investing with Fundrise.
My wife and I have now been investing with Fundrise for approximately 4.5 years. We cannot wait to share another episode with you, the performance and the additional income that the investment can provide! Continue reading
Pharmaceutical stocks have not had a great year, at all, in 2023. Many of the big name companies we all know of, are down this year, as the stock market trudges forward, now up over 15% this year.
Given that – it was time to look at the name that has headlined a lot of the hate lately, Pfizer (PFE) stock. Continue reading